Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients
Clinical trial NCT02231580 · TERMINATED
Trial details
- NCT number
- NCT02231580
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-03-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.